Technology
Health
Biotechnology

Dare Bioscience

$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (8.43%) Today
-$0.01 (-0.52%) After Hours

Why Robinhood?

You can buy or sell DARE and other stocks, options, ETFs, and crypto commission-free!

About

Daré Bioscience, Inc. operates as a healthcare company. It engages in the development and commercialization of pharmaceutical products in women's reproductive health. Read More Its products inclide Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert, and Roger L. Hawley in 2015 and is headquartered in La Jolla, CA.

Employees
5
Headquarters
La Jolla, California
Founded
2015
Market Cap
20.33M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
675.66K
High Today
$2.10
Low Today
$1.82
Open Price
$1.82
Volume
893.65K
52 Week High
$3.25
52 Week Low
$0.60

Collections

Technology
Health
Biotechnology
Healthcare
Pharmaceutical
2014 IPO
US
North America

News

MarketWatchMar 18

Dare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment study

Shares of Daré Bioscience Inc. DARE, +139.13% rocketed 129% on very heavy volume toward a 13-month high in afternoon trade Monday, after the biopharmaceutical company announced positive findings for the use of its DARE-VVA1 product candidate in treating vulvar and vaginal atrophy (VVA). The stock was the biggest percentage gainer listed on major U.S. exchanges, even though it pared earlier gains of as much as 253%. Volume swelled to 37.8 million shares, compared with the full-day average of about 82,500 sha...

1,327
BenzingaMar 18

Dare Bioscience Skyrockets On Positive Data For Vaginal Dryness Drug (NASDAQ:DARE)

Dare Bioscience Inc (NASDAQ: DARE), a nanocap biotech company focused on developing therapies for women's health, is enjoying a moment in the spotlight thanks to positive results for its vaginally administered tamoxifen.

188

Earnings

-$1.42
-$0.95
-$0.47
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.